The Journal of Immunology, Vol 157, Issue 2 617-624, Copyright © 1996 by American Association of Immunologists

ARTICLES

Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation

MT Michalek, EP Grant and KL Rock
Alpha-Beta Technology, Worcester, MA 01605, USA.

Class I presentation of microinjected native OVA by a temperature- sensitive ubiquitin conjugation mutant, ts85, but not wild-type murine cells, was markedly inhibited following incubation at a nonpermissive temperature. In contrast, the nonpermissive temperature did not affect class I presentation of a minimal OVA peptide expressed in the cytosol. Therefore, these results provide a second example in which a temperature sensitive mutation in the ubiquitin conjugation pathway inhibits MHC class I presentation of native OVA. Surprisingly, incubation at the nonpermissive temperature did not inhibit class I presentation of chemically denatured and alkylated OVA microinjected into the cytosol of mutant cells. Similarly, the presentation of endogenously synthesized OVA (which is expressed from a recombinant vaccinia virus and, presumably, is misfolded in the cytosol) was also not inhibited in both mutant cell lines. Methylation of the lysine groups in denatured OVA, which blocks ubiquitin conjugation, reduced but did not eliminate the presentation of denatured OVA, providing evidence for both ubiquitin-dependent and ubiquitin-independent pathways for class I presentation. In contrast, a proteasome inhibitor blocked class I presentation of all forms of OVA, while a control peptide aldehyde was not inhibitory. These results indicate that modification of the structure of a protein can influence its requirements for ubiquitin conjugation for efficient class I presentation, with the key alteration possibly being the loss of proper conformation. However, regardless of the form of the Ag, the proteasome appears to be required for generating peptides from both endogenously synthesized and microinjected OVA for class I presentation.

This article has been cited by other articles:

				S.-B. Qian, M. F. Princiotta, J. R. Bennink, and J. W. Yewdell Characterization of Rapidly Degraded Polypeptides in Mammalian Cells Reveals a Novel Layer of Nascent Protein Quality Control J. Biol. Chem., January 6, 2006; 281(1): 392 - 400. [Abstract] [Full Text] [PDF]

				R. F. Kalejta and T. Shenk Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein PNAS, March 18, 2003; 100(6): 3263 - 3268. [Abstract] [Full Text] [PDF]

				P. Mukherjee, A. Dani, S. Bhatia, N. Singh, A. Y. Rudensky, A. George, V. Bal, S. Mayor, and S. Rath Efficient Presentation of Both Cytosolic and Endogenous Transmembrane Protein Antigens on MHC Class II Is Dependent on Cytoplasmic Proteolysis J. Immunol., September 1, 2001; 167(5): 2632 - 2641. [Abstract] [Full Text] [PDF]

				C. J. Luckey, J. A. Marto, M. Partridge, E. Hall, F. M. White, J. D. Lippolis, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Differences in the Expression of Human Class I MHC Alleles and Their Associated Peptides in the Presence of Proteasome Inhibitors J. Immunol., August 1, 2001; 167(3): 1212 - 1221. [Abstract] [Full Text] [PDF]

				M. Benharouga, M. Haardt, N. Kartner, and G. L. Lukacs COOH-terminal Truncations Promote Proteasome-dependent Degradation of Mature Cystic Fibrosis Transmembrane Conductance Regulator from Post-Golgi Compartments J. Cell Biol., May 21, 2001; 153(5): 957 - 970. [Abstract] [Full Text] [PDF]

				D. J. Shedlock and D. B. Weiner DNA vaccination: antigen presentation and the induction of immunity J. Leukoc. Biol., December 1, 2000; 68(6): 793 - 806. [Abstract] [Full Text]

				X. Y. Mo, P. Cascio, K. Lemerise, A. L. Goldberg, and K. Rock Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides J. Immunol., December 1, 1999; 163(11): 5851 - 5859. [Abstract] [Full Text] [PDF]

				A. F. Kisselev, T. N. Akopian, K. M. Woo, and A. L. Goldberg The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes. IMPLICATIONS FOR UNDERSTANDING THE DEGRADATIVE MECHANISM AND ANTIGEN PRESENTATION J. Biol. Chem., February 5, 1999; 274(6): 3363 - 3371. [Abstract] [Full Text] [PDF]

				C. J. Luckey, G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Proteasomes Can Either Generate or Destroy MHC Class I Epitopes: Evidence for Nonproteasomal Epitope Generation in the Cytosol J. Immunol., July 1, 1998; 161(1): 112 - 121. [Abstract] [Full Text] [PDF]

				S. Ben-Shahar, B. Cassouto, L. Novak, A. Porgador, and Y. Reiss Production of a Specific Major Histocompatibility Complex Class I-restricted Epitope by Ubiquitin-dependent Degradation of Modified Ovalbumin in Lymphocyte Lysate J. Biol. Chem., August 22, 1997; 272(34): 21060 - 21066. [Abstract] [Full Text] [PDF]

				A. Craiu, M. Gaczynska, T. Akopian, C. F. Gramm, G. Fenteany, A. L. Goldberg, and K. L. Rock Lactacystin and clasto-Lactacystin beta -Lactone Modify Multiple Proteasome beta -Subunits and Inhibit Intracellular Protein Degradation and Major Histocompatibility Complex Class I Antigen Presentation J. Biol. Chem., May 16, 1997; 272(20): 13437 - 13445. [Abstract] [Full Text] [PDF]

				N. P. N. Emmerich, A. K. Nussbaum, S. Stevanovic, M. Priemer, R. E. M. Toes, H.-G. Rammensee, and H. Schild The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein Substrate J. Biol. Chem., July 7, 2000; 275(28): 21140 - 21148. [Abstract] [Full Text] [PDF]